Public Company News

ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...

2025-12-08 09:02 2161

Daesang Group's "Vietnam Scholarship Quiz Show" Advances Youth Talent Development Through Respect

* Record participation as over 100,000 students nationwide compete in Vietnam's premier academic quiz show * Hanoi student Đinh Bảo Khánh earns top honor, receives a 200 million VND scholarship SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- Daesang Group announced that the "Vietnam Scholar...

2025-12-08 09:00 2859

CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting

SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell product candidate, CT0596, for the treatment of relapsed/r...

2025-12-08 08:15 3883

ProstACT Global Phase 3 Update: First Patient Dosed in Randomized Treatment Expansion, Part 1 Readout Plans Confirmed

MELBOURNE, Australia and INDIANAPOLIS, Dec. 8, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient has been dosed in Part 2 (randomized treatment expansion) of its ProstACT Global Phase 3 study evaluating its lead prostate can...

2025-12-08 06:08 2122

CARsgen's CAR-T Product Zevor-Cel Included in China's Commercial Health Insurance Innovative Drug Catalogue

SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced today announced with great pleasure that its independently developed fully human BCMA-targeted CAR-T product, zevorcabtage...

2025-12-07 17:21 4328

All Approved Indications of Five Akeso's Innovative Drugs Included in China's Latest NRDL: Featuring Two First-in-Class Bispecifics with New First-Line Indications and Three Newly Negotiated Drugs

HONG KONG, Dec. 7, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the successful inclusion of all five of the Company's self-developed innovative drugs into the updated National Reimbursement Drug List (NRDL) for 2025, released byChina's National Healthcare Securi...

2025-12-07 14:18 2528

Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List

SAN FRANCISCO and SUZHOU, China, Dec. 6, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...

2025-12-07 11:40 3070

SK hynix Honored with Two Major Titles at GSA Awards 2025

* Company named "Best Financially Managed Semiconductor Company (Achieving Greater than$1 Billion in Annual Sales)" and "Outstanding Asia-Pacific Semiconductor Company" simultaneously * Accelerates recovery from market downturn leveraging world-class HBM leadership; Global management performa...

2025-12-07 07:48 3098

Blokees exhibits at CCXP25 in Brazil: World Premiere of the New Saint Seiya Product

SHANGHAI, Dec. 6, 2025 /PRNewswire/ -- From December 4 to 7, Assembly Character Toys brand Blokees made its first debut at Brazil Comic Con Experience (CCXP). Blokees exhibited its two major categories "Blokees Model Kits" and "BLOKEES WHEELS", with nearly 60 products based on over 10 world-renow...

2025-12-06 23:50 6328

/C O R R E C T I O N -- Seegene Inc./

In the news release, "Seegene Establishes French Subsidiary to Expand European Footprint", issued05-Dec-2025 by Seegene Inc. over PR Newswire, we are advised by the company that the first sub-headline should read "France becomes Seegene's eighth overseas sales subsidiary and third inEurope, follo...

2025-12-06 00:00 5136

NYSE Content Advisory: Pre-Market Update + NYSE Becomes Exclusive Exchange Partner of LA-Based Video Podcast TBPN

NEW YORK, Dec. 5, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content advisory: Pre Market Update + NYSE Becomes Exclusive...

2025-12-05 22:00 6048

Neurophet Participates RSNA 2025, Showcased Real-World Clinical Use Cases of 'Neurophet AQUA AD'

* Demonstrated brain imaging analysis solutions, including 'Neurophet AQUA AD,' which enables monitoring of adverse effects associated with Alzheimer's disease treatments * Highlighted clinical cases that improved the safety of anti-amyloid therapy administration during an AI Theater session ...

2025-12-05 22:00 6287

PAVS Achieves 18,037% YoY Revenue Increase in 2025 Interim Results

NEW YORK, Dec. 5, 2025 /PRNewswire/ -- Paranovus Entertainment Technology Limited ("the Company"), listed on Nasdaq, today announced its financial results for the six months endedSeptember 30, 2025, achieving substantial revenue increase and a meaningful improvement in gross profit following its ...

2025-12-05 21:45 6047

Kling AI Launches Video 2.6 Model with "Simultaneous Audio-Visual Generation" Capability, Redefining AI Video Creation Workflow

HONG KONG, Dec. 5, 2025 /PRNewswire/ -- Kuaishou Technology ("Kuaishou" or the "Company"; HKD Counter Stock Code: 01024 / RMB Counter Stock Code: 81024), a leading content community and social platform, announced that onDecember 3, 2025 , Kling AI released the Kling Video 2.6 Model. This update in...

2025-12-05 21:33 9693

Marvion Inc. Signs Exclusive Client Referral MOU with STAR Warehouse Engineering Limited, Strengthening Warehouse Engineering, Logistics Capacity and Corporate Client Acquisition

HONG KONG, Dec. 5, 2025 /PRNewswire/ -- Marvion Inc. (OTCQB: MVNC) today announced that it has entered into a12-month binding Memorandum of Understanding (MOU) with STAR Warehouse Engineering Limited ("STAR"). Under the agreement, STAR willexclusively and with priority refer its engineering clien...

2025-12-05 21:18 5895

China Automotive Systems Advances High-Torque Intelligent Steering Motors to Mass Production for Commercial Vehicles

WUHAN, China, Dec. 5, 2025 /PRNewswire/ -- China Automotive Systems, Inc. (NASDAQ: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier inChina, today announced that its subsidiary, Hyoseong ( Wuhan) Motion Mechatronics System Co. Ltd., has entered the final co...

2025-12-05 19:00 4980

XIAO NOODLES Debuts on HKEX, Becoming the First Listed Chinese Noodle Restaurant Stock

HONG KONG, Dec. 5, 2025 /PRNewswire/ -- Guangzhou Xiao Noodles Catering Management Co., Ltd. ("XIAO NOODLES" or the "Company", Stock Code:2408.HK), a prominent Chinese specialty restaurant chain, was officially listed today on the Main Board of the Hong Kong Stock Exchange, becoming thefirst Chin...

2025-12-05 18:45 4315

IBM Designated as a Critical Third-Party Provider Under EU DORA

ARMONK, N.Y., Dec. 5, 2025 /PRNewswire/ -- The Digital Operational Resilience Act (DORA) is a European Union regulation designed to ensure that financial entities—such as banks, insurance companies, and investment firms—and their critical Information and Communication Technology (ICT) providers c...

2025-12-05 18:00 3486

Zoomlion Recognized as Top-Tier Smart Factory at 2025 World Intelligent Manufacturing Conference

CHANGSHA, China, Dec. 5, 2025 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion"; 1157.HK) was named one of the first 15 industry-leading smart factories at the 2025 World Intelligent Manufacturing Conference onNovember 27, 2025. The Company's breakthrough in share...

2025-12-05 16:22 4349

TransThera Publishes Clinical Studies of Tinengotinib (TT-00420) against Cholangiocarcinoma on Lancet

NANJING, China and GAITHERSBURG, Md., Dec. 4, 2025 /PRNewswire/ -- TransThera Sciences Inc. ("TransThera") announced the publication of clinical results from a US-based Phase 2 trial evaluating tinengotinib in patients with Cholangiocarcinoma (CCA) on The Lancet Gastroenterology and Hepatology (I...

2025-12-05 12:31 2468